Adeola Fagunloye, Ph.D (@adeolafagunloye) 's Twitter Profile
Adeola Fagunloye, Ph.D

@adeolafagunloye

@PennMedicine @pennbgs #CancerResearcher #DNARepair #Pharmacist|Alumni @UPMCHillmancc|Perfume/NFT collector #InGodWeTrust🌏

ID: 250114214

linkhttps://www.linkedin.com/in/adeolafagunloye/ calendar_today10-02-2011 13:08:05

7,7K Tweet

1,1K Followers

608 Following

BiotechTV (@biotechtvhq) 's Twitter Profile Photo

CAR-T for Glioblastoma: Penn Medicine's Dr. Donald O'Rourke describes advances being seen today in using CAR-T against glioblastoma. Penn Medicine - Abramson Cancer Center Full video: biotechtv.com/post/penn-medi…

nature (@nature) 's Twitter Profile Photo

US drug regulators dropped a bombshell in November 2023 when they announced an investigation into one of the most celebrated cancer treatments to emerge in decades go.nature.com/4acmi90

Science News (@sciencnews) 's Twitter Profile Photo

How to avoid burnout Credit: Victoria Repa #PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science

How to avoid burnout

Credit: Victoria Repa #PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma dlvr.it/T85wPF

Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma dlvr.it/T85wPF
Kara Bernstein (@kara_bernstein) 's Twitter Profile Photo

Excited for our pub. in Nature Communications, Human Shu complex promotes RAD51 activity by modulating RPA dynamics on ssDNA, Congrats to ⁦@science_SRH⁩ ⁦Ben Van Houten⁩ ⁦Chelsea⁩ ⁦Maria Spies, PhD (she/her)⁩ ⁦Matt Schaich⁩ et al nature.com/articles/s4146…

Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

Liquid biopsy: a promising tool for cancer screening, but sensitivity for early-stage detection remains a challenge. Innovation is key to improving outcomes. Critical Reviews in Oncology Hematology (CROH) The Journal of Liquid Biopsy #LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24 Christian Rolfo ELO International Society of Liquid Biopsy

Liquid biopsy: a promising tool for cancer screening, but sensitivity for early-stage detection remains a challenge. Innovation is key to improving outcomes.

<a href="/CHematology/">Critical Reviews in Oncology Hematology (CROH)</a> <a href="/jlb_islb/">The Journal of Liquid Biopsy</a> #LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24
<a href="/ChristianRolfo/">Christian Rolfo</a> <a href="/ElJanLe/">ELO</a> <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
Kara Bernstein (@kara_bernstein) 's Twitter Profile Photo

So incredibly proud of Adeola for successfully defending his dissertation last week. Our understanding of the Shu complex role in finding replicative DNA damage has now been revealed ….stay tuned.

So incredibly proud of Adeola for successfully defending his dissertation last week.  Our understanding of the Shu complex role in finding replicative DNA damage has now been revealed ….stay tuned.
U.S. Surgeon General (@surgeon_general) 's Twitter Profile Photo

NEW: Today, I’m releasing a Surgeon General’s Advisory on the causal link between alcohol consumption and increased cancer risk. Alcohol is the 3rd leading preventable cause of cancer in the U.S., contributing to about 100,000 cancer cases and 20,000 cancer deaths each year.

NEW: Today, I’m releasing a Surgeon General’s Advisory on the causal link between alcohol consumption and increased cancer risk. Alcohol is the 3rd leading preventable cause of cancer in the U.S., contributing to about 100,000 cancer cases and 20,000 cancer deaths each year.
Eric Topol (@erictopol) 's Twitter Profile Photo

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism" —the 1st human to undergo custom genome editing —outgrowth of decades of NIH funded research nejm.org/doi/full/10.10… nejm.org/doi/full/10.10… NEJM

Today "a milestone in the evolution of personalized therapies for rare &amp; ultra-rare inborn errors of metabolism"
—the 1st human to undergo custom genome editing
—outgrowth of decades of NIH funded research
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10… <a href="/NEJM/">NEJM</a>
HHMI (@hhminews) 's Twitter Profile Photo

A baby named KJ, who was born with a rare genetic disorder – CPS1 deficiency – is healed thanks to doctors at the Children's Hospital who administered the world’s first personalized gene-editing treatment. The research team used base editing, a gene-editing method invented by HHMI

A baby named KJ, who was born with a rare genetic disorder – CPS1 deficiency – is healed thanks to doctors at the <a href="/ChildrensPhila/">Children's Hospital</a> who administered the world’s first personalized gene-editing treatment. The research team used base editing, a gene-editing method invented by HHMI
Sternberg Lab (@sternberglab) 's Twitter Profile Photo

1/10 Today in Science Magazine in collaboration with liugroup we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells. drive.google.com/file/d/1I-UbCR…

1/10 Today in <a href="/ScienceMagazine/">Science Magazine</a> in collaboration with <a href="/liugroup/">liugroup</a> we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells. drive.google.com/file/d/1I-UbCR…
nature (@nature) 's Twitter Profile Photo

An innovative genome-editing tool promises to do what original CRISPR systems have struggled to achieve: insert entire genes, precisely and efficiently, into human DNA go.nature.com/430GeeB